Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consolidation Therapy With Bortezomib <= 60 Year Old Patients With Multiple Myeloma

NCT00416273 is registered in ClinicalTrials.gov with Janssen-Cilag G.m.b.H as lead sponsor.

NCT NCT00416273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00416273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consolidation Therapy With Bortezomib <= 60 Year Old Patients With Multiple Myeloma
Lead sponsor
Janssen-Cilag G.m.b.H
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
May 31, 2013
Enrollment
217 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma